Market Overview:
The global oral contraceptive drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of unplanned pregnancies, rising awareness about oral contraceptives, and technological advancements in the field of contraception. Based on type, the global oral contraceptive drugs market can be segmented into long-acting contraceptives, short-acting contraceptives, and emergency contraceptives. Of these segments, the short-acting contraceptives segment is expected to witness highest growth during the forecast period owing to their easy availability and low cost as compared to other types of oral contraceptive drugs. Based on application, the global oral contraceptive drugs market can be divided into hospital pharmacies and retail pharmacies. The hospital pharmacies segment is anticipated to account for a larger share of this market during the forecast period owing to increased use of these drugs for preventing unintended pregnancies in women admitted in hospitals. However, with growing awareness about Oral Contraceptives (OCs), there is an increasing trend towards self-medication which is likely propel growth prospects for retail pharmacies segment over coming years .
Product Definition:
Oral contraceptive drugs are a form of birth control that is taken in pill form. They work by preventing ovulation and sperm from entering the uterus. Oral contraceptives are important because they are easy to use, reliable, and have a low risk of side effects.
Long-acting Contraceptives:
Long-acting reversible Contraceptives (LARCs) are a group of birth control methods that includes intrauterine devices (IUD), subdermal implants, and oral contraceptives. The use of LARCs does not require daily maintenance and has no effect on the probability of pregnancy after discontinuation.
Short-acting Contraceptives:
Short-acting contraceptives are a group of birth control pills, implants, and IUDs (intrauterine devices) that prevent pregnancy by acting as an artificial ovary. They may work for up to three years. The most common types of short-acting contraceptive drugs are the progesterone-only pill, the mini-pill or oral contraceptive pill, and the subdermal implant.
Application Insights:
The other application segment includes clinics, public places and the like. The use of contraceptives at these places is considered to be a social responsibility to protect future generations from unplanned pregnancies. Thus, various organizations have been demanding the government take measures to regulate this practice under acceptable conditions.
In addition, many governments are taking initiatives for improving access to family planning services by setting up modern facilities in hospitals and pharmacies with trained staff for providing oral contraceptives in a safe manner. Furthermore, growing awareness about available contraceptive options among women as well as men is expected to boost market growth over the forecast period.
On the basis of application, the global oral contraceptive drugs market has been segmented into hospital pharmacy Other or unspecified place or time ¢â‚¬Ëœ clinics public places and others (excluding healthcare) .
Regional Analysis:
Asia Pacific dominated the global oral contraceptive drugs market in 2017. This can be attributed to rising awareness about contraceptives, increasing population, and growing demand for effective contraceptives among women of all age groups in this region. The Asia Pacific is also expected to be the fastest-growing regional market during the forecast period due to a large population base and easy availability of various brands of oral contraceptives at affordable prices.
The Latin American market is anticipated to grow at a significant rate over the forecast period owing to factors such as high unmet need, rise in awareness about modern contraception methods, increase in government initiatives & programs for distribution & promotion of contraceptive products/services along with economic development & improvement leading towards higher standard of living with changing consumer lifestyle patterns which has resulted into increased usage rates for these highly effective yet economical drugs across this region.
Growth Factors:
- Rising awareness about oral contraceptive drugs and their benefits among women of reproductive age group.
- Increasing incidence of unplanned pregnancies, which is driving the demand for oral contraceptive drugs.
- Growing trend of using contraceptives to space births and prevent unwanted pregnancies.
- Availability of a wide range of oral contraceptive drugs in the market catering to different needs and preferences of women consumers.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Contraceptive Drugs Market Research Report
By Type
Long-acting Contraceptives, Short-acting Contraceptives, Emergency Contraceptives
By Application
Hospital, Pharmacy, Other
By Companies
Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Oral Contraceptive Drugs Market Report Segments:
The global Oral Contraceptive Drugs market is segmented on the basis of:
Types
Long-acting Contraceptives, Short-acting Contraceptives, Emergency Contraceptives
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Pfizer
- Teva Pharmaceutical
- Merck
- Actavis
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
Highlights of The Oral Contraceptive Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Long-acting Contraceptives
- Short-acting Contraceptives
- Emergency Contraceptives
- By Application:
- Hospital
- Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Contraceptive Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral contraceptive drugs are a type of birth control that work by preventing the release of eggs from the ovaries. They are taken by mouth (by pill, patch, ring, or injection) and can be used for many years. Oral contraceptives may also be used to prevent pregnancy after having sex.
Some of the key players operating in the oral contraceptive drugs market are Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong.
The oral contraceptive drugs market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Contraceptive Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Contraceptive Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Contraceptive Drugs Market - Supply Chain
4.5. Global Oral Contraceptive Drugs Market Forecast
4.5.1. Oral Contraceptive Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Contraceptive Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Contraceptive Drugs Market Absolute $ Opportunity
5. Global Oral Contraceptive Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Contraceptive Drugs Market Size and Volume Forecast by Type
5.3.1. Long-acting Contraceptives
5.3.2. Short-acting Contraceptives
5.3.3. Emergency Contraceptives
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Contraceptive Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Contraceptive Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Pharmacy
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Contraceptive Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Contraceptive Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Contraceptive Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Contraceptive Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Contraceptive Drugs Demand Share Forecast, 2019-2026
9. North America Oral Contraceptive Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Contraceptive Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Contraceptive Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Pharmacy
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Contraceptive Drugs Market Size and Volume Forecast by Type
9.7.1. Long-acting Contraceptives
9.7.2. Short-acting Contraceptives
9.7.3. Emergency Contraceptives
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Contraceptive Drugs Demand Share Forecast, 2019-2026
10. Latin America Oral Contraceptive Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Contraceptive Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Contraceptive Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Pharmacy
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Contraceptive Drugs Market Size and Volume Forecast by Type
10.7.1. Long-acting Contraceptives
10.7.2. Short-acting Contraceptives
10.7.3. Emergency Contraceptives
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Contraceptive Drugs Demand Share Forecast, 2019-2026
11. Europe Oral Contraceptive Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Contraceptive Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Contraceptive Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Pharmacy
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Contraceptive Drugs Market Size and Volume Forecast by Type
11.7.1. Long-acting Contraceptives
11.7.2. Short-acting Contraceptives
11.7.3. Emergency Contraceptives
11.8. Bass Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Contraceptive Drugs Demand Share, 2019-2026
12. Asia Pacific Oral Contraceptive Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Contraceptive Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Contraceptive Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Pharmacy
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Contraceptive Drugs Market Size and Volume Forecast by Type
12.7.1. Long-acting Contraceptives
12.7.2. Short-acting Contraceptives
12.7.3. Emergency Contraceptives
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Contraceptive Drugs Demand Share, 2019-2026
13. Middle East & Africa Oral Contraceptive Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Contraceptive Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Contraceptive Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Pharmacy
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Contraceptive Drugs Market Size and Volume Forecast by Type
13.7.1. Long-acting Contraceptives
13.7.2. Short-acting Contraceptives
13.7.3. Emergency Contraceptives
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Contraceptive Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Contraceptive Drugs Market: Market Share Analysis
14.2. Oral Contraceptive Drugs Distributors and Customers
14.3. Oral Contraceptive Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Teva Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Actavis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Gedeon Richter
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Novo Nordisk A/S
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ZiZhu
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Baijingyu
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Huazhong
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
